Kevin Fernando
@drkevinfernando
Followers
5K
Following
7K
Media
785
Statuses
5K
Portfolio GP, GPwER Diabetes/CVRM & Medical Education, Content Advisor @Medscape Global & UK, Honorary Clinical Reader @dundeeuni
Haddington, Scotland
Joined October 2014
🔥Metformin & #SGLT2i for almost all in draft @NICEComms #t2d guidance! ⚠️But no drug is without harm & we must balance the benefits against possible adverse effects 💡Have a look at my @YouTube videos for people living with #T2D considering #sglt2is
https://t.co/Lrz1EBiMtE
0
16
44
Retatrutide TRIUMPH-4: 29% weight loss at 12mg. Impressive. ⚠️But here’s what needs discussing: 20.9% experienced dysesthesia (abnormal skin sensations) at that dose vs 0.7% placebo. Before everyone panics: - Generally mild - Rarely led to discontinuation - Overall dropout
1
14
22
Just me for my last @MediConfUK of the year! 🔑Key takeaways 🎯Top tips & pitfalls to avoid when interpreting eGFR & UACR 🎯New therapeutic options for CKD & DKD - SGLT2i’s, finerenone, semaglutide 🎯Management of hyperkalaemia in primary care
For UK HCPs: Join @drkevinfernando for his final MediConf webinar of the year. Make sure to secure your free place today: https://t.co/katbPlzMf0
0
0
2
💪🏾Mind the Muscle: Incretin Therapies for Weight Loss💪🏾 🔥The hottest of topics with incretin therapies🔥 Here's my last @Medscape perspective piece from @ObesitySociety @ObesityWeek congress in Atlanta - link in comments 👇🏾
1
1
5
Insight delivered. Expertise shared. The first sessions of #CVRMUK2025 tackled emerging evidence in cardio-renal medicine. Key takeaways already echo across disciplines: integration matters. Looking forward to exploring how these insights translate to everyday clinical decisions.
0
3
5
Today marks the opening of #CVRMUK2025 where cardio-renal-metabolic care meets collaborative innovation. Whether you're a GPSI, a nephrologist, nurse or pharmacist, this is your opportunity to shape future pathways. Let's connect, exchange insight and accelerate patient outcomes.
0
1
3
CVRMUK2025 starts tomorrow! If you're working at the front line of CVRM care you know: The pressure is real. The system is stretched. That's why hundreds of GPs, nephrologists, nurses, pharmacists + dietitians are gathering tomorrow. Still want to join👉 https://t.co/1dbAn4Lorb
0
1
2
#GLP1 is forcing Big Food to finally reform. Not through regulation, but ⤵️💰 12% of US adults on GLP-1s = ⤵️8.6% in household food spending. 🔹Ultra-processed foods hit hardest 🔸 $12bn potential loss for junk food. Nestlé, General Mills, even Greggs scrambling to
8
22
83
⏳ One week to go! Hear from @drkevinfernando & @drpatrickholmes on what they’re most excited about at #CVRMUK2025. 📅 26 Nov, The King’s Fund Don’t miss out - register now 👉 https://t.co/Y7FMY9iiTv
#CardiometabolicHealth #HCPs
0
1
2
Global leaders united at the GHA One World Summit 2025 to drive action on global health, SDGs, and digital transformation moving towards a more connected and resilient future. 🌍✨ #GHA1W #GlobalHealth #OneWorldSummit #LeadershipForChange
#CNN #BBC #CNBC #NDTV #SkyNews #TimesNow
0
10
11
⏳ 2 weeks to go! Want to know why our conferences are so popular with HCPs? Hear from Prof Saqib Mahmud on why he attended our last conference. 📅 CVRMUK Autumn Conference: 26 Nov @kingsfund Still time to join us 👉 https://t.co/1dbAn4KQBD
#CVRMUK2025 #HCPs #MedicalEducation
0
1
1
Pharmacological therapies for type 2 diabetes: future approaches. An excellent review by our own Birmingham Prof Cliff Bailey @sribellary @m_alikaramat @AmeliaCookDSN @AmarPut @SamaraAfzal @UHBDiabetes
link.springer.com
Diabetologia - Despite the availability of at least nine differently acting classes of glucose-lowering agents, many people with type 2 diabetes do not achieve or maintain sufficiently tight...
1
4
11
🛫I'm off to Atlanta next week to attend @ObesitySociety ObesityWeek® congress for the first time Let me know if you are also attending - it would be great to meet up 👍🏾The programme is wide-ranging, with the below sessions piquing my interest:
0
0
3
For UK HCPs: 💻Join us this Saturday, 1st November from 9:30-11:30 for an interactive webinar on Rash Reasoning presented by Dr Catherine Fernando. Book your place here: https://t.co/CvbIDFp877
#primarycare #medicalwebinars #dermatology
0
1
1
🚨SELECT trial surprise🚨 💉 Semaglutide ⤵️cardiovascular events 20% regardless of wt loss. 🔸👫losing <5% had same CV benefit as those losing >5%. 🔹Only 33% of benefit explained by waist circ. changes. 👉Reframes GLP-1s from weight loss drugs to CV disease modifiers. 🔗
1
51
132
💡The first step in healthcare is self-care 🔥My latest @Medscape Medical Mentor podcast is live! 🚨Improving cardiometabolic health in #T2D, focusing on the importance of 24-hour physical behaviours for people living with #T2D or the 5 𝗦's On @Spotify & @ApplePodcasts
2
1
9